This training program has been designed to provide pre- and postdoctoral candidates with the individual intellectual and technical skills required to become outstanding academic scientists in the field of immunobiology.
The aim i s to utilize the growth of Immunobiology and the expansion of its faculty at Mount Sinai as a resource to create a fertile environment for the growth of graduate students and postdoctoral fellows. Each trainee will be exposed not only to direct laboratory research, but will have the opportunity (actually be required) to participate in the educational programs focused on Immunobiology established here at Mount Sinai. For physician scientists there will be ample opportunity to immerse themselves in translational research programs relating to cytokine biology, HIV related disorders, mucosal immunity, autoimmunity and primary immune deficiency. There is formal course work, seminar series, journal clubs and work in progress meetings (attended by the entire Immunology faculty and trainees). A single faculty member acts as a preceptor for a given fellow or graduate student supervising his/her laboratory work, orchestrating an appropriate training program (e.g. course work), and providing an environment that will help foster maturation towards an independent career in immunology research. The program has successfully recruited outstanding trainees from a number of prestigious institutions who have been attracted to Mount Sinai because of the enormous growth in the basic sciences, excellence in research, a protective and nurturing mentoring environment and a clear commitment to student and post-doctoral fellowship training.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007605-09
Application #
8102082
Study Section
Special Emphasis Panel (ZAI1-QV-I (M2))
Program Officer
Prograis, Lawrence J
Project Start
2001-07-01
Project End
2013-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
9
Fiscal Year
2011
Total Cost
$165,221
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Saxena, Mansi; Balan, Sreekumar; Roudko, Vladimir et al. (2018) Towards superior dendritic-cell vaccines for cancer therapy. Nat Biomed Eng 2:341-346
Saxena, Mansi; Bhardwaj, Nina (2018) Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment. Trends Cancer 4:119-137
Agudo, Judith; Park, Eun Sook; Rose, Samuel A et al. (2018) Quiescent Tissue Stem Cells Evade Immune Surveillance. Immunity 48:271-285.e5
Audenet, François; Farkas, Adam M; Anastos, Harry et al. (2018) Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer. World J Urol 36:1741-1748
Ang, Rosalind L; Ting, Adrian T (2018) Detection of RIPK1 in the FADD-Containing Death Inducing Signaling Complex (DISC) During Necroptosis. Methods Mol Biol 1857:101-107
Li, Cheuk Wun; Osman, Roman; Menconi, Francesca et al. (2017) Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. J Autoimmun 76:1-9
Li, Cheuk Wun; Menconi, Francesca; Osman, Roman et al. (2016) Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis. J Biol Chem 291:4079-90
Mathern, Douglas R; Heeger, Peter S (2015) Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol 10:1636-50
Campisi, L; Cummings, R J; Blander, J Magarian (2014) Death-defining immune responses after apoptosis. Am J Transplant 14:1488-98
Swartz, Talia H; Esposito, Anthony M; Durham, Natasha D et al. (2014) P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J Virol 88:11504-15

Showing the most recent 10 out of 19 publications